PepTivator EBV EBNA-1, human, 6 nmol
货号：
130-093-613 基本售价：
询价 规格：
EA
产品信息
概述| 货号 | 130-093-613 |
| 描述 | The PepTivator® EBV EBNA-1 is a peptide pool that consists mainly of 15-mer peptides with 11 amino acids overlap, covering the complete sequence of the Epstein-Barr virus EBNA-1 protein (UniProt ID: P03211).PepTivator peptide pools have been developed for the efficient in vitro stimulation of antigen–specific CD4+ and CD8+ T cells, as peptides of 15-aa length with 11 aa overlap represent an optimized solution for stimulating both CD4+and CD8+ T cells in various applications.1Quantitative, phenotypical, or functional analysis of EBV EBNA-1–specific T cell immunity can provide important information on the natural course of immune responses in healthy or immunocompromised individuals.PepTivator EBV EBNA-1-HT is a peptide pool lyophilized in the wells of a 96-well plate, allowing stimulation and analysis of cells directly on the plate. The convenient 96-well format, composed of 12 individually removable strips of 8 wells each allows for easy and flexible experimental set-up, different antigens can be combined by assembling different strips. A control can also be added easily by using strips from the Control plate (12x8). |
性能| 供应商 | Miltenyi |
| 背景 | Epstein-Barr virus (EBV) is a human γ-herpes virus with B cell growth–transforming ability and lymphomagenic potential. More than 90% of human adults are infected with EBV. Usually the primary infection is asymptomatic, but some individuals develop an infectious mononucleosis, a self-limiting lymphoproliferative disease. The Epstein-Barr nuclear antigen 1 (EBNA-1) protein is involved in the replication of viral episomes and therefore crucial for the persistence of the infection. Its expression is maintained in all latency cycles of infection and in all EBV-associated malignancies. EBNA-1-specific CD4+ and CD8+ T cells have been found in EBV-infected individuals.2–5 |
